Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1999 3
2001 1
2002 1
2006 4
2007 1
2008 5
2009 5
2010 8
2011 11
2012 4
2013 12
2014 13
2015 8
2016 16
2017 4
2018 12
2019 15
2020 7
2021 12
2022 18
2023 23
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Sickle Cell Disease.
Pecker LH, Lanzkron S. Pecker LH, et al. Among authors: lanzkron s. Ann Intern Med. 2021 Jan;174(1):ITC1-ITC16. doi: 10.7326/AITC202101190. Epub 2021 Jan 12. Ann Intern Med. 2021. PMID: 33428443 Review.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: lanzkron s. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
The reply.
Naik RP, Streiff MB, Lanzkron S. Naik RP, et al. Among authors: lanzkron s. Am J Med. 2013 Oct;126(10):e15. doi: 10.1016/j.amjmed.2013.06.006. Am J Med. 2013. PMID: 24054961 No abstract available.
Pain without gain: steroids and sickle crisis.
Lanzkron S, Pecker L. Lanzkron S, et al. Blood. 2022 Jun 30;139(26):3678-3679. doi: 10.1182/blood.2022016070. Blood. 2022. PMID: 35771559 Free article. No abstract available.
Sickle Cell Disease: New Approaches for an Old Disease.
Lanzkron S, Little J. Lanzkron S, et al. Hematol Oncol Clin North Am. 2022 Dec;36(6):xiii-xiv. doi: 10.1016/j.hoc.2022.09.001. Hematol Oncol Clin North Am. 2022. PMID: 36400546 No abstract available.
Kneeling Was the First Step for Sickle Cell Disease.
Desai P, Little J, Kanter J, Bridges K, Andemariam B, Lanzkron S. Desai P, et al. Among authors: lanzkron s. Ann Intern Med. 2021 Jul;174(7):1004-1005. doi: 10.7326/M20-7418. Epub 2021 Mar 23. Ann Intern Med. 2021. PMID: 33750189 No abstract available.
Time to recognize an overlooked trait.
Cavanaugh KL, Lanzkron S. Cavanaugh KL, et al. Among authors: lanzkron s. J Am Soc Nephrol. 2010 Mar;21(3):385-6. doi: 10.1681/ASN.2010010070. Epub 2010 Feb 4. J Am Soc Nephrol. 2010. PMID: 20133485 Free PMC article. No abstract available.
175 results